Sprout Capital and Sprout Growth healthcare technology portfolio performance data (as of March 31, 2014)
Sprout Capital and Sprout Growth healthcare technology portfolio performance data (as of March 31, 2014) The document lists investment amounts, returns, and IRRs for a private venture fund's healthcare technology portfolio. It contains no direct references to high‑profile individuals, government agencies, or controversial transactions, limiting its investigative value. However, the detailed financial figures could be a modest lead for tracing capital flows if linked to known political donors or lobbyists, meriting a low‑to‑moderate score. Key insights: Provides cost, realized value, and IRR for each portfolio company.; Total invested $101.2 M with $260.0 M realized value for Sprout Capital VIL (18.6% IRR).; Sprout Growth II shows $161 M invested with $70.9 M realized value (43.8% IRR).
Summary
Sprout Capital and Sprout Growth healthcare technology portfolio performance data (as of March 31, 2014) The document lists investment amounts, returns, and IRRs for a private venture fund's healthcare technology portfolio. It contains no direct references to high‑profile individuals, government agencies, or controversial transactions, limiting its investigative value. However, the detailed financial figures could be a modest lead for tracing capital flows if linked to known political donors or lobbyists, meriting a low‑to‑moderate score. Key insights: Provides cost, realized value, and IRR for each portfolio company.; Total invested $101.2 M with $260.0 M realized value for Sprout Capital VIL (18.6% IRR).; Sprout Growth II shows $161 M invested with $70.9 M realized value (43.8% IRR).
Tags
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,500+ persons in the Epstein files. 100% free, ad-free, and independent.